Long-term Outcome of 525 Patients With Mycosis Fungoides and Sézary Syndrome
Top Cited Papers
Open Access
- 1 July 2003
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of Dermatology
- Vol. 139 (7) , 857-866
- https://doi.org/10.1001/archderm.139.7.857
Abstract
MYCOSIS fungoides (MF) and the Sézary syndrome (SS) are a group of extranodal non–Hodgkin lymphomas of T-cell origin with primary cutaneous involvement.1 The group distinguishes itself from other cutaneous T-cell lymphomas by its unique clinical and histological features. Mycosis fungoides is an uncommon lymphoma; however, it is the most common primary lymphoma of the skin.Keywords
This publication has 14 references indexed in Scilit:
- Clinical Characteristics and Outcome of Patients With Extracutaneous Mycosis FungoidesJournal of Clinical Oncology, 2001
- Prognostic significance of tumor burden in the blood of patients with erythrodermic primary cutaneous T-cell lymphomaBlood, 2001
- Detection of a Peripheral Blood T Cell Clone is an Independent Prognostic Marker in Mycosis FungoidesJournal of Investigative Dermatology, 2000
- Prognostic factor analysis in mycosis fungoides/Sézary syndromeJournal of the American Academy of Dermatology, 1999
- Clinical Characteristics and Long-term Outcome of Patients With Generalized Patch and/or Plaque (T2) Mycosis FungoidesArchives of Dermatology, 1999
- Prognostic factors in Sézary syndrome: A multivariate analysis of clinical, haematological and immunological featuresAnnals of Oncology, 1998
- Increased serum concentration of the soluble interleukin-2 receptor in cutaneous T-cell lymphoma. Clinical and prognostic implicationsArchives of Dermatology, 1996
- Lymph node classification systems in cutaneous T-cell lymphoma. Evidence for the utility of the working formulation of non-Hodgkin's lymphomas for clinical usageCancer, 1994
- Clinical Staging for Cutaneous T-Cell LymphomaAnnals of Internal Medicine, 1984
- Prognostic variables in mycosis fungoidesCancer, 1981